Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 90: 1189-1195, 2001;
8750-7587/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ren, X.
Right arrow Articles by Robbins, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ren, X.
Right arrow Articles by Robbins, P. A.
Vol. 90, Issue 4, 1189-1195, April 2001

Respiratory control in humans after 8 h of lowered arterial PO2, hemodilution, or carboxyhemoglobinemia

Xiaohui Ren, Keith L. Dorrington, and Peter A. Robbins

University Laboratory of Physiology, University of Oxford, Oxford OX1 3PT, United Kingdom


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

In humans exposed to 8 h of isocapnic hypoxia, there is a progressive increase in ventilation that is associated with an increase in the ventilatory sensitivity to acute hypoxia. To determine the relative roles of lowered arterial PO2 and oxygen content in generating these changes, the acute hypoxic ventilatory response was determined in 11 subjects after four 8-h exposures: 1) protocol IH (isocapnic hypoxia), in which end-tidal PO2 was held at 55 Torr and end-tidal PCO2 was maintained at the preexposure value; 2) protocol PB (phlebotomy), in which 500 ml of venous blood were withdrawn; 3) protocol CO, in which carboxyhemoglobin was maintained at 10% by controlled carbon monoxide inhalation; and 4) protocol C as a control. Both hypoxic sensitivity and ventilation in the absence of hypoxia increased significantly after protocol IH (P < 0.001 and P < 0.005, respectively, ANOVA) but not after the other three protocols. This indicates that it is the reduction in arterial PO2 that is primarily important in generating the increase in the acute hypoxic ventilatory response in prolonged hypoxia. The associated reduction in arterial oxygen content is unlikely to play an important role.

hypoxia; carbon monoxide; ventilation; oxygen content


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

WHEN HUMANS ARE EXPOSED TO an environment of low oxygen for prolonged periods, ventilation (VE) increases progressively, and this is accompanied by a reduction in end-tidal PCO2 (PETCO2). This process is known as ventilatory acclimatization to hypoxia (VAH). The mechanisms that underlie VAH are not yet fully understood. However, as part of this process, there is an increase in the sensitivity of the ventilatory response to acute hypoxia (AHVR) (13, 27, 32). A number of studies in goats suggest that this increase in AHVR has its origins within the carotid body. Hypoxia localized to the carotid body was found to induce VAH (3, 29), whereas systemic hypoxia did not induce VAH if the carotid body was maintained euoxic (31). By way of contrast, in a study conducted in awake ponies, Lowry et al. (18) reported that there was a progressive fall in arterial PCO2 during several hours of steady carboxyhemoglobinemia. Because this induces tissue hypoxia within the brain but has little effect at the carotid body (9, 17), they concluded that their results were consistent with a central nervous mechanism contributing to the early phase of VAH in ponies.

In view of the somewhat conflicting conclusions drawn from these studies, we decided to compare, in humans, an 8-h reduction in arterial O2 content (CaO2) brought about by a reduction in arterial PO2 (PaO2) with 8-h reductions in CaO2 in which PaO2 remained unaffected. If the increase in AHVR associated with VAH is primarily due to brain hypoxia, then a rise in AHVR would be expected from both types of exposure. On the other hand, if the increase in AHVR associated with VAH is primarily due to carotid body hypoxia, then a reduction in CaO2 without a reduction in PaO2 should have little effect (3, 9, 17, 29). Rather than employ just one method to reduce CaO2 at constant PaO2, we decided to use two protocols, employing hemodilution and carbon monoxide (CO) inhalation, respectively.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Subjects

Twelve healthy subjects (9 men, 3 women) participated in the study. Their age ranged between 20 and 32 yr, with an average of 23 ± 4 (SD) yr. Their average height was 180 ± 19 cm, and their average weight was 74 ± 13 kg. All were nonsmokers except for subject 1,128, who smoked 10 cigarettes per day. None of the subjects had donated blood within the 6 mo before his or her participation in the study. All were requested to have a light breakfast and refrain from alcohol, caffeine-containing drink, and cigarettes on each experimental day. Female subjects only participated in the experiments during the first 14 days of their menstrual cycles. The basic experimental procedure was explained to all subjects, but they were naive as to the exact purpose of the experiments. Each subject visited the laboratory once or twice before undertaking any of the main experimental protocols to become familiar with the laboratory and its procedures. All subjects gave informed consent before participating in the study. The study was approved by the Central Oxford Research Ethics Committee.

Protocols

Each subject undertook four different protocols. Protocol IH consisted of an 8-h exposure to isocapnic hypoxia, in which end-tidal PO2 (PETO2) was held at 55 Torr and PETCO2 was maintained at the subject's air-breathing control value. During protocol PB, each subject underwent phlebotomy, with 500 ml of blood being withdrawn from an arm vein. During protocol CO, a ~10% level of carboxyhemoglobin (HbCO) was induced and maintained for 8 h by having the subjects intermittently breathe a dilute mixture of CO in air. Protocol C was a control protocol, in which the subjects breathed air with no other intervention. The order of the exposures was varied among subjects. At least 4 wk were allowed to elapse after protocol PB before another experimental protocol was undertaken. Each experiment started at 8-9 AM after the subject had rested for at least 0.5 h at the laboratory. A light lunch was served at 12:30-1 PM.

Air-breathing PETCO2 was measured before and after each 8-h protocol. AHVR was assessed before, 40 min after, and 8 h after the start of each 8-h protocol. During each measurement of AHVR, PETO2 was held at 100 Torr for the first 5 min. This was followed by six square waves of PETO2, with PETO2 alternating between 1 min at 50 Torr and 1 min at 100 Torr. PETCO2 was held at 1-2 Torr above the subject's initial air-breathing value throughout. The end-tidal gas profiles used are illustrated in Fig. 1, which is from an actual determination of AHVR in one subject (subject 1,118).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   Example of assessment of acute hypoxic ventilatory response. End-tidal PCO2 (PETCO2), end-tidal PO2 (PETO2), and ventilation (VE) were recorded breath by breath. Data are from subject 1,118 at the start of protocol C (control).

Experimental Technique

At the beginning of each experimental day, a venous blood sample of 1-2 ml was taken to determine the total concentration of hemoglobin ([Hb]; g/dl), the percentage of methemoglobin (%MetHb), and the percentage of HbCO (%HbCO).

Protocol IH. To undertake the 8-h exposures to hypoxia associated with this protocol, we employed a purpose-built chamber. The subject was seated comfortably inside the chamber and wore a fine catheter at the opening of each nostril through which respired gas was sampled and analyzed by mass spectrometry for PO2 and PCO2. A pulse oximeter was attached to the forefinger to monitor percent arterial oxygen saturation (SaO2). A computer was used to analyze and log the data on-line, to identify inspiratory and end-tidal values of PO2 and PCO2, and to control the gas composition within the chamber. At the start of each experiment, the composition of the inspired gas that would be required to produce the desired PETCO2 and PETO2 was estimated and set manually before the subject entered the chamber. After the subject entered the chamber, the inspiratory gas composition was adjusted automatically by the computer every 5 min or at manually overridden intervals, to minimize the difference between the actual and the target values for PETCO2 and PETO2. The system has been described in detail before (12).

Protocol PB. The phlebotomy associated with this protocol consisted of removing 500 ml of blood from a vein in the antecubital fossa. To determine the degree of hemodilution achieved, two further venous blood samples were taken at 40 min and at 8 h after phlebotomy.

Protocol CO. The CO inhalation associated with this protocol was undertaken by asking the subject to inspire a concentration of 0.4% CO in air through a loose fitting face mask. (For subject 1,136, who was the first subject to undergo this procedure, a concentration of 0.1% CO in air was used, which was found to increase the level of HbCO rather too slowly.) Before the start of CO inhalation, a catheter was inserted into a cephalic vein. During CO inhalation, blood samples of 1-2 ml were taken every 5 min through the catheter to measure %HbCO. The period of CO inhalation lasted 10-30 min, and the inhalation was stopped when %HbCO reached ~10%. After the period of inhalation, blood samples were taken every ~1.5 h to measure %HbCO. "Topping-up" inhalations of CO were performed when %HbCO had declined to ~9%. Generally, this was necessary three to four times during the 8-h period.

Measurement of air-breathing PETCO2 and AHVR. These measurements were made with the subjects seated in an upright position. Values for air-breathing PETCO2 were determined by using a nasal catheter connected to a mass spectrometer. During measurements of AHVR, subjects breathed through a mouthpiece with their nose occluded with a clip. Ventilatory volumes were measured by a turbine volume-measuring device (15) fixed in series with the mouthpiece. Respired gas was sampled continuously and analyzed by mass spectrometry for PCO2 and PO2. A pulse oximeter was attached to the forefinger to monitor the SaO2. Data were recorded on-line by a computer, which also determined PETCO2 and PETO2 from the signals from the mass spectrometer.

The desired end-tidal gas profiles were generated by using an end-tidal forcing system. Before the experiment started, a forcing function was calculated. This consisted of the predicted inspired gas compositions on a second-by-second basis that would be required to produce the desired levels of PETO2 and PETCO2 in the subject. The function was input into a controlling computer, which was used to regulate the gas mixtures breathed by the subject. During the course of the experiment, measured values for PETO2 and PETCO2 were fed to the controlling computer on a breath-by-breath basis from the data-acquisition computer. The deviations of these actual values from the desired values were used to adjust the new inspiratory gas mixtures by using an integral-proportional feedback control scheme. The controlling computer adjusted the inspired partial pressures of N2, O2, and CO2 through a fast gas-mixing system (14). This control scheme has been described in more detail elsewhere (23).

Data Analysis

Calculation of CaO2. In protocol IH, CaO2 (ml/100 ml) was calculated as
Ca<SUB>O<SUB>2</SUB></SUB><IT>=1.39·</IT>[Hb]<IT>·</IT><FR><NU><IT>100−%</IT>HbCO<IT>−%</IT>MetHb</NU><DE><IT>100</IT></DE></FR><IT>·</IT><FR><NU>Sa<SUB>O<SUB>2</SUB></SUB></NU><DE><IT>100</IT></DE></FR>
where the values for [Hb], %HbCO, and %MetHb were taken from the initial blood sample and for SaO2 from the pulse oximeter reading. In protocol PB, the same equation was used, but the value for SaO2 came from the initial reading from the pulse oximeter, values for %HbCO and %MetHb came from the initial blood sample, and the values for [Hb] were determined from the blood samples drawn during the exposure.

In protocol CO, accurate calculation of CaO2 is a little more involved because of the cooperative nature of binding between the four subunits of the hemoglobin molecule. To calculate CaO2, we used the basic assumption of Roughton and Darling (24) that the amount of deoxyhemoglobin present with a mixture of CO and O2 is the same as if no CO were present and the PO2 values were replaced by PO2 + M · PCO, where M is the relative affinity of hemoglobin between CO and O2 given by
<FR><NU>P<SC>o</SC><SUB>2</SUB><IT>·%</IT>HbCO</NU><DE>P<SC>co</SC> · Sa<SUB>O<SUB>2</SUB></SUB></DE></FR><IT>=M</IT>
The value used for M was 218 (5). The initial air-breathing value for PETO2 was used in this equation together with values for %HbCO, as obtained from venous blood samples. Values for PCO and SaO2 could then be obtained by numerically solving the above relationship simultaneously with the Adair equation for the hemoglobin dissociation curve, with the values for PO2 in the Adair equation replaced by (PO2 + M · PCO)
<FR><NU>Sa<SUB>O<SUB>2</SUB></SUB></NU><DE><IT>100</IT></DE></FR><IT>=</IT><FR><NU><IT>A<SUB>1</SUB>P+2A<SUB>2</SUB>P<SUP>2</SUP>+3A<SUB>3</SUB>P<SUP>3</SUP>+4A<SUB>4</SUB>P<SUP>4</SUP></IT></NU><DE><IT>4</IT>(<IT>1+A<SUB>1</SUB>+A<SUB>2</SUB>P<SUP>2</SUP>+A<SUB>3</SUB>P<SUP>3</SUP>+A<SUB>4</SUB>P<SUP>4</SUP></IT>)</DE></FR>
where
P=(P<SC>o</SC><SUB>2</SUB><IT>+M·</IT>P<SC>co</SC>)
The coefficients (A1-4) used for the Adair equation were those obtained by Roughton and Severinghaus (25) to ensure accuracy in the upper range of the dissociation curve.

Model fitting. To quantify AHVR from the data, the responses to the six square waves of hypoxia were fitted by a single-compartment model (model 3) as described by Clement and Robbins (4). In this model, total VE is divided into hypoxia-dependent (peripheral; Vp) and hypoxia-independent (central; Vc) components. In our assessment of AHVR, isocapnia was maintained, and so Vc can be assumed to be constant. As the hypoxic stimulus varied over time, Vp needs to be expressed in a time-varying form and is represented in the model as
&tgr; <FR><NU>d<A><AC>V</AC><AC>˙</AC></A><SUB>p</SUB></NU><DE>d<IT>t</IT></DE></FR><IT>+</IT><A><AC>V</AC><AC>˙</AC></A><SUB>p</SUB><IT>=</IT>G<SUB>p</SUB>[<IT>100−S</IT>(<IT>t−T</IT><SUB>d</SUB>)]
where t is time, Gp is the hypoxic sensitivity, tau  is a time constant, Td is a time delay, and S is SaO2 (%) calculated from PETO2 as described by Severinghaus (28).

To fit the model to the data, a difference equation was obtained from the model to describe the model output for the current breath in terms of the model output for the previous breath, the input function, and the parameters of the model. These calculations were described in detail for this model by Clement and Robbins (4).

The parameters of the model, Gp, Vc, tau , and Td, were estimated by nonlinear regression. This was undertaken by using the Numerical Algorithms Group (Oxford, UK) FORTRAN library routine E04FDF to minimize the sum of squares of the residuals.

Statistical analysis. ANOVA was used to test for possible differences in the parameters among the four protocols, where protocol and time of measurements were treated as fixed factors and the subject as a random factor. Statistical significance was accepted at P < 0.05.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Subjects

From the 12 subjects originally recruited for the study, 11 finished all of the experiments. Subject 1,132 felt faint during phlebotomy and subsequently decided to leave the study. Subject 1,138 felt faint at the end of phlebotomy, and his heart rate decreased to 45 beats/min. Atropine (0.6 mg) was administrated intravenously, the subject recovered within minutes, and he then completed the experiment. All other subjects completed all protocols uneventfully.

PETO2, SaO2, [Hb], %HbCO, and CaO2 During the Protocols

Table 1 lists the values for PETO2 and SaO2 (obtained via pulse oximetry) for all 11 subjects before and during the 8 h of isocapnic hypoxia associated with protocol IH. The values indicate that PETO2 was well controlled during the 8-h exposure. CaO2 was calculated from SaO2 and the oxygen-carrying capacity of the blood, as determined from the venous blood sample drawn at the start of the experiment. These values are shown in Table 1. During the hypoxic exposure, a 7.5% reduction in CaO2 was generated.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   PETO2, SaO2, and CaO2 before (t = 0) and during (t = 1-8 h) protocol IH

Table 2 lists the values for [Hb] for all of the subjects before, 40 min after, and 8 h after the phlebotomy associated with protocol PB. Although the blood loss was ~10% of total blood volume, the overall change in [Hb] after 8 h was only 0.5 g/100 ml. Values for CaO2 were calculated from the oxygen-carrying capacity of the blood, as determined from the venous blood samples, by assuming that air-breathing SaO2 remained constant at the mean value determined by pulse oximetry. Values for CaO2 are listed in Table 2. Overall, CaO2 had fallen by 4% at 8 h after phlebotomy.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   [Hb] and CaO2 before (t = 0), 40 min after, and 8 h after phlebotomy in protocol PB

Table 3 lists the values for %HbCO for protocol CO. The mean value for %HbCO during the 8-h period of elevated HbCO was 9.7%, which represented an increase of 7.3% over the control level of 2.4%. Values for CaO2 were calculated in the manner described in METHODS and are listed in Table 3. The mean reduction in CaO2 with CO exposure was 7.4%.

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   %HbCO and CaO2 before (t = 0) and during (t = 1-8 h) protocol CO

Air-Breathing PETCO2 and AHVR

Values for air-breathing PETCO2 before and after each protocol are shown in Table 4. ANOVA revealed that the different protocols had significantly different effects on air-breathing PETCO2 (P < 0.001). Post hoc analysis revealed that the fall in PETCO2 associated with protocol IH was significantly different from the modest rises in PETCO2 observed with the other protocols. The other protocols did not differ significantly one from another.

                              
View this table:
[in this window]
[in a new window]
 
Table 4.   Air-breathing PETO2 and PETCO2 before and after protocols IH, PB, CO, and C

The averages for Gp and Vc across all the subjects are shown in Fig. 2 for the time points of t = 0, 40 min, and 8 h for each protocol. ANOVA revealed that there were significant differences over time among protocols (P < 0.001). Post hoc analysis revealed that both Gp and Vc had increased significantly after 8 h in protocol IH, but no significant differences over time were detected for either protocol PB or protocol CO.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 2.   Group means ± SE of hypoxic sensitivity (Gp) and hypoxia-insensitive VE (Vc) across all subjects before (time = 0), at 40 min, and at 8 h during each exposure. IH, PB, CO, and C: isocapnic hypoxia, phlebotomy, carboxyhemoglobin, and control protocols, respectively. Significantly different from previous time points of same protocol: ** P < 0.001, * P < 0.005.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The main finding of the present study was that, whereas 8 h of reduced PaO2 and CaO2 induced significant elevations in both Gp and Vc and a significant decrease in air-breathing PETCO2, 8 h of reduced CaO2 with PaO2 maintained at normal levels did not affect Gp, Vc, or air-breathing PETCO2. This finding indicates that it is the prolonged reduction of PaO2 that is primarily important in inducing the increase in AHVR in the early stages of VAH. The associated modest decrease in CaO2 does not appear to play an important role. We consider that the results from this study provide further support for the notion that the early phases of ventilatory acclimatization to modest hypoxia arise through the effects of hypoxia at the carotid body rather than within the central nervous system.

Experimental Limitations of the Study

The intention of the study design was to generate the same reduction in CaO2 in each of the three protocols. In protocol IH, the reduction in CaO2 was 7.5%; in protocol PB, the reduction was 4.2%; and in protocol CO, the reduction was 7.4%. Thus protocols IH and CO were well matched in terms of the reduction in CaO2, but this was not the case for protocol PB. In retrospect, a better study design for protocol PB would have been to replace the 500 ml of blood with 500 ml of a plasma expander. The relatively small fall in CaO2 in protocol PB limits the usefulness of these observations. However, our laboratory has recently observed (8) that a very modest reduction in inspired PO2 over an 8-h period, which resulted in a fall in CaO2 of only ~2.7%, can induce acclimatization in terms of a significant increase in Gp and Vc and fall in air-breathing PETCO2. This finding suggests that the 4.2% reduction in CaO2 in protocol PB should have been sufficient to induce acclimatization, if the acclimatization process had indeed been triggered by a reduction in CaO2 in the absence of a change in PETO2.

Other Limitations and Assumptions of the Study

In relation to drawing any conclusions about the site of action of hypoxia in early VAH, it is necessary to make some assumptions on the likely effect of the three intervention protocols on the tissue PO2 of the sites in question. The first assumption is that protocol IH would have had a significant effect on the PO2 at the carotid body but that neither protocol PB nor protocol CO would have done so. In relation to protocol IH, it was clearly the case that the reduction in PETO2 had a substantial acute effect on VE. However, Ayres et al. (1) have reported that, during modest increases in %HbCO of ~9% in patients, there may also be some reduction in PaO2. They attributed this to a widening of the alveolar-arterial PO2 gradient, brought about by an increase in the effect of shunt within the lungs because of the reduction of PO2 in venous blood. However, these effects were only really significant for patients who had abnormally high alveolar-arterial PO2 gradients; in patients with normal alveolar-arterial PO2 gradients, the effect was small. Furthermore, other studies in humans have found that neither 9% HbCO (11) nor 18-20% HbCO (30) had any significant effect on VE. In animal studies of CO inhalation, VE did not increase until %HbCO had reached 45-50% (2, 7, 9). In an animal study of acute anemia, VE did not increase until hematocrit had fallen to 50-60% of the original value (19). In studies of carotid body function in animals, neither increases in %HbCO that were considerably greater than in the present study nor decreases in hematocrit that were considerably greater than in the present study had any significant effect on the nerve- discharge frequency from the carotid body (10, 17).

A second assumption that we make is that protocols PB and CO would have induced a reduction in brain tissue PO2 that would have been quantitatively similar to that observed with protocol IH. Figure 3 illustrates the calculated fall in venous PO2 (PvO2) as a function of the amount of oxygen extracted from the blood for protocol IH, and for idealized versions of protocols PB and CO, where the initial reduction in CaO2 is precisely matched to that of protocol IH. The horizontal line indicates the PO2 calculated from the Adair equation (25) for a venous O2 saturation of 60.4%, which is a typical value for jugular venous blood under control conditions (6). The vertical lines indicate lower and upper limits for the likely range for jugular venous O2 content (CO2). The vertical line at the lower CO2 was calculated by assuming that there was no increase in cerebral blood flow, and the vertical line at the higher CO2 was calculated by assuming that cerebral blood flow increased by 8.7%, as measured for isocapnic hypoxia with PETO2 of 50 Torr (20). The calculated fall in PvO2 was less for protocol PB than for the other two protocols and is only ~1 Torr below normal. The calculated falls in PvO2 for protocols IH and CO were similar and are ~3.5 Torr below normal. The calculated fall for protocol CO was ~0.5 Torr more marked than for protocol IH. These calculations suggest that, even if protocol PB had engendered a reduction in CaO2 equal to that of the other two protocols, it would not have been as effective in lowering brain PO2. On the other hand, protocols IH and CO are likely to have been well matched with respect to their effect on brain PO2.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Calculated fall in blood PO2 with decreasing blood O2 content (CO2) for protocol IH (solid curve), protocol PB (long dashed curve), and protocol CO (short dashed curve). Vertical lines, likely upper and lower estimates for CO2 of jugular venous blood. Horizontal line, equivalent PO2 from Adair equation associated with jugular venous O2 saturation of 60.4%.

Another issue that is related to protocol CO is that CO could have some physiological effects other than those associated with the reduction in CaO2 (16, 21, 22). It has been shown that exogenous CO at very high partial pressure (500-550 Torr) stimulated carotid body sensory discharge under normoxic conditions. A relatively low level of PCO <=  140 Torr did not stimulate the chemosensory discharge during normoxia but inhibited the chemosensory response to hypoxia (16). Obviously, these levels of PCO are orders of magnitude greater than those used in protocol CO.

Comparison of Results with Other Longer Term Studies of CO Inhalation and Hemodilution in Animals

There are very few data from animal studies to compare with our results in humans. In ponies, Lowry et al. (18) increased %HbCO to ~25% over a period of ~1 h and then maintained it at this level for a further 5 h. During this period, there was a progressive decrease in arterial PCO2, which was similar to that observed with a 5-h exposure to low PaO2. In goats, progressive hemodilution produced a consistent increase in AHVR after 3 days when [Hb] was reduced from ~10-12 to 6-7 g/100 ml. However, a reduction in [Hb] to 7-8 g/100 ml had little effect (26). In both of these studies, the stimulus employed to obtain a progressive effect of increased %HbCO or hemodilution on VE and/or AHVR was substantially greater than in the present study. The present study suggests that these effects of %HbCO and hemodilution do not occur in humans unless a fairly substantial degree of tissue hypoxia is induced, and, therefore, they are unlikely to underlie ventilatory acclimatization to mild or moderate hypoxia.


    ACKNOWLEDGEMENTS

We thank D. O'Connor for skilled technical assistance.


    FOOTNOTES

This study was supported by the Wellcome Trust. X. Ren held an Overseas Research Students Award and was supported by a K. C. Wong Scholarship.

Address for reprint requests and other correspondence: P. A. Robbins, Univ. Laboratory of Physiology, Parks Road, Oxford OX1 3PT, United Kingdom (E-mail: peter.robbins{at}physiol.ox.ac.uk).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 29 December 1999; accepted in final form 12 October 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Ayres, SM, Giannelli S, Jr, and Mueller H. Myocardial and systemic responses to carboxyhemoglobin. Ann NY Acad Sci 174: 268-293, 1970[ISI][Medline].

2.   Bureau, MA, Carroll JL, and Canet E. Response of newborn lambs to CO-induced hypoxia. J Appl Physiol 64: 1870-1877, 1988[Abstract/Free Full Text].

3.   Busch, MA, Bisgard GE, and Forster HV. Ventilatory acclimatization to hypoxia is not dependent on arterial hypoxemia. J Appl Physiol 58: 1874-1880, 1985[Abstract/Free Full Text].

4.   Clement, ID, and Robbins PA. Dynamics of the ventilatory response to hypoxia in humans. Respir Physiol 92: 253-275, 1993[ISI][Medline].

5.   Coburn, RF, and Forman HJ. Carbon monoxide toxicity. In: Handbook Of Physiology. The Respiratory System. Gas Exchange. Bethesda, MD: Am. Physiol. Soc, 1987, sect. 3, vol. IV, chapt. 21, p. 439-456.

6.   Cohen, PJ, Alexander SC, Smith TC, Reivich M, and Wollman H. Effects of hypoxia and normocarbia on cerebral blood flow and metabolism in conscious man. J Appl Physiol 23: 183-189, 1967[Free Full Text].

7.   Doblar, DD, Santiago TV, and Edelman NH. Correlation between ventilatory and cerebrovascular responses to inhalation of CO. J Appl Physiol 43: 455-462, 1977[Abstract/Free Full Text].

8.  Fatemian M, Kim DY, Poulin MJ, and Robbins, PA. Very mild exposure to hypoxia for 8 h can induce ventilatory acclimatization in humans. Eur J Physiol. In press.

9.   Gautier, H, and Bonora M. Ventilatory response of intact cats to carbon monoxide hypoxia. J Appl Physiol 55: 1064-1071, 1983[Abstract/Free Full Text].

10.   Hatcher, JD, Chiu LK, and Jennings DB. Anemia as a stimulus to aortic and carotid chemoreceptors in the cat. J Appl Physiol 44: 696-702, 1978[Abstract/Free Full Text].

11.   Hausberg, M, and Somers VK. Neural circulatory responses to carbon monoxide in healthy humans. Hypertension 29: 1114-1118, 1997[Abstract/Free Full Text].

12.   Howard, LSGE, Barson RA, Howse BPA, McGill TR, McIntyre ME, O'Connor DF, and Robbins PA. A chamber for controlling the end-tidal gas tensions over sustained periods in humans. J Appl Physiol 78: 1088-1091, 1995[Abstract/Free Full Text].

13.   Howard, LSGE, and Robbins PA. Alterations in respiratory control during eight hours of isocapnic and poikilocapnic hypoxia in humans. J Appl Physiol 78: 1098-1107, 1995[Abstract/Free Full Text].

14.   Howson, MG, Khamnei S, McIntyre ME, O'Connor DF, and Robbins PA. A rapid computer-controlled binary gas-mixing system for studies in respiratory control. J Physiol (Lond) 394: 7P, 1987.

15.   Howson, MG, Khamnei S, O'Connor DF, and Robbins PA. The properties of a turbine device for measuring respiratory volumes in man. J Physiol (Lond) 382: 12P, 1986.

16.   Lahiri, S, Iturriaga R, Mokashi A, Ray DK, and Chugh D. CO reveals dual mechanisms of O2 chemoreception in the cat carotid body. Respir Physiol 94: 227-240, 1993[ISI][Medline].

17.   Lahiri, S, Mulligan E, Nishino T, Mokashi A, and Davies RO. Relative responses of aortic body and carotid body chemoreceptors to carboxyhemoglobinemia. J Appl Physiol 50: 580-586, 1981[Abstract/Free Full Text].

18.   Lowry, TF, Forster HV, Korducki MJ, Forster AL, and Forster MA. Comparison of ventilatory responses to sustained reduction in arterial oxygen tension vs. content in awake ponies. J Appl Physiol 76: 2147-2153, 1994[Abstract/Free Full Text].

19.   Matsuoka, T, Saiki C, and Mortola JP. Metabolic and ventilatory response to anemic hypoxia in conscious rats. J Appl Physiol 77: 1067-1072, 1994[Abstract/Free Full Text].

20.   Poulin, MJ, and Robbins PA. Influence of cerebral blood flow on the ventilatory response to hypoxia in humans. Exp Physiol 83: 95-106, 1998[Abstract].

21.   Prabhakar, NR. Endogenous carbon monoxide in control of respiration. Respir Physiol 114: 57-64, 1998[ISI][Medline].

22.   Prabhakar, NR. NO and CO as second messengers in oxygen sensing in the carotid body. Respir Physiol 115: 161-168, 1999[ISI][Medline].

23.   Robbins, PA, Swanson GD, and Howson MG. A prediction-correction scheme for forcing alveolar gases along certain time courses. J Appl Physiol 52: 1353-1357, 1982[Abstract/Free Full Text].

24.   Roughton, FJW, and Darling RC. The effect of carbon monoxide on the oxyhemoglobin dissociation curve. Am J Physiol 141: 17-31, 1944.

25.   Roughton, FJW, and Severinghaus JW. Accurate determination of O2 dissociation curve of human blood above 98.7% saturation with data on O2 solubility in unmodified human blood from 0° to 37°C. J Appl Physiol 35: 861-869, 1973[Free Full Text].

26.   Santiago, TV, Edelman NH, and Fishman AP. The effect of anemia on the ventilatory response to transient and steady-state hypoxia. J Clin Invest 55: 410-418, 1975.

27.   Sato, M, Severinghaus JW, Powell FL, Xu F-D, and Spellman MJ, Jr. Augmented hypoxic ventilatory response in men at altitude. J Appl Physiol 73: 101-107, 1992[Abstract/Free Full Text].

28.   Severinghaus, JW. Simple, accurate equations for human blood O2 dissociation computations. J Appl Physiol 46: 599-602, 1979[Abstract/Free Full Text].

29.   Smith, CA, Bisgard GE, Nielsen AM, Daristotle L, Kressin NA, Forster HV, and Dempsey JA. Carotid bodies are required for ventilatory acclimatization to chronic hypoxia. J Appl Physiol 60: 1003-1010, 1986[Abstract/Free Full Text].

30.   Vogel, JA, and Gleser MA. Effect of carbon monoxide on oxygen transport during exercise. J Appl Physiol 32: 234-239, 1972[Free Full Text].

31.   Weizhen, N, Engwall MJA, Daristotle L, Pizarro J, and Bisgard GE. Ventilatory effects of prolonged systemic (CNS) hypoxia in awake goats. Respir Physiol 87: 37-48, 1992[ISI][Medline].

32.   White, DP, Gleeson K, Pickett CK, Rannels AM, Cymerman A, and Weil JV. Altitude acclimatization: influence on periodic breathing and chemoresponsiveness during sleep. J Appl Physiol 63: 401-412, 1987[Abstract/Free Full Text].


J APPL PHYSIOL 90(4):1189-1195
8750-7587/01 $5.00 Copyright © 2001 the American Physiological Society



This article has been cited by other articles:


Home page
Exp PhysiolHome page
H. E. Wood, M. Fatemian, and P. A. Robbins
Respiratory: Prior sustained hypoxia attenuates interaction between hypoxia and exercise as ventilatory stimuli in humans
Exp Physiol, January 1, 2007; 92(1): 273 - 286.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ren, X.
Right arrow Articles by Robbins, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ren, X.
Right arrow Articles by Robbins, P. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online